A 64-year-old man was initially treated with adriamycin, carmustine, CY and melphalan for symptomatic multiple myeloma. Following a poor response the patient was switched to oral melphalan, which was ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback